ASX Limited

ASX

ASX Ltd. engages in operating a securities exchange. The company is headquartered in Sydney, New South Wales and currently employs 1,140 full-time employees. The firm is engaged in offering listings, trading, clearing, settlement, technical and information services, technology, data and other post-trade services. The company acts as a market operator, clearing house and payments system facilitator. The ASX operates markets for a range of asset classes including equities, fixed income, commodities, and energy. Its activities span primary and secondary market services, including the raising, allocation and hedging of capital flows; trading and price discovery; central counterparty risk transfer, and securities settlement for both the equities and fixed income markets. ASX operates through four divisions: listings, markets, technology and data, and securities and payments. The company also provides data and technology services to intermediaries, banks, information vendors and software developers to help them make decisions, offer services to their clients and connect with one another.

Atomo Diagnostics Limited

AT1

Atomo Diagnostics Ltd. engages in manufacture, research, development, and design of in-vitro medical devices for blood-based rapid diagnostic testing (RDT) for professional use and self-testing. The firm supplies integrated rapid diagnostic test (RDT) devices to the global diagnostic market. The Company’s patented devices simplify testing procedures, enhance usability and improve reliability across rapid point-of-care (POC) and at-home testing applications. The firm has commercialized a number of products across international markets and has supply agreements in place for testing applications targeting infectious diseases, including COVID-19, HIV, viral vs bacterial differentiation and female health. Its products include Atomo HIV Self-Test, AtomoRapid HIV (1&2) and ATOMONOW Pregnancy Test. Its Atomo HIV Self-Test is an integrated, blood-based rapid diagnostic test (RDT) for HIV screening, which provides results in 15 minutes. Its AtomoRapid HIV (1&2) integrates multiple test components into the device platform. AtomoRapid HIV (1&2) needs a small drop of blood to give results in 15 minutes.

Asra Minerals Limited

ASR

Asra Minerals Ltd. engages in the development and exploration of mineral properties. The company is headquartered in Perth, Western Australia. The firm is focused on targeting a growing gold, lithium and rare earth element (REE) portfolio in the premier Goldfields region of Western Australia. The Company’s flagship Mt Stirling Project is located 240 kilometers (km) north of Kalgoorlie and hosts 10 gold prospects, and a gold JORC Mineral Resource. The project also has a potential for REE and critical minerals including scandium. Its Kookynie West Project is situated less than 50km south, which is an underexplored site showing gold, lithium and REE potential. The company also has two lithium-focused exploration projects in the southern Yilgarn area of Western Australia at Lake Johnston and Lake Cowan, located in highly prospective ground between operating lithium mines at Earl Grey and Bald Hill. Its footprint in the Eastern Goldfields region stands at approximately 1,134 square kilometers (km2).